SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-19-226895
Filing Date
2019-08-22
Accepted
2019-08-22 16:22:32
Documents
2
Group Members
BCIP LIFE SCIENCES ASSOCIATES, LP

Document Format Files

Seq Description Document Type Size
1 SC 13D d64544dsc13d.htm SC 13D 71066
2 EX-99.A d64544dex99a.htm EX-99.A 6226
  Complete submission text file 0001193125-19-226895.txt   78821
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Subject) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-80035 | Film No.: 191046327
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 CLARENDON STREET BOSTON MA 02116
Business Address 200 CLARENDON STREET BOSTON MA 02116 617-516-2000
Bain Capital Life Sciences Fund, L.P. (Filed by) CIK: 0001687968 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D